SKENDER, Belma, Jiřina HOFMANOVÁ and Alena VACULOVÁ HYRŠLOVÁ. Docosahexaenoic fatty acid (DHA) in the regulation of colon cell growth and cell death: A review. BIOMEDICAL PAPERS-OLOMOUC. OLOMOUC: PALACKY UNIV, MEDICAL FAC, 2012, vol. 156, No 3, p. 186-199. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2012.093.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Docosahexaenoic fatty acid (DHA) in the regulation of colon cell growth and cell death: A review
Authors SKENDER, Belma (70 Bosnia and Herzegovina, guarantor), Jiřina HOFMANOVÁ (203 Czech Republic, belonging to the institution) and Alena VACULOVÁ HYRŠLOVÁ (203 Czech Republic).
Edition BIOMEDICAL PAPERS-OLOMOUC, OLOMOUC, PALACKY UNIV, MEDICAL FAC, 2012, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 0.990
RIV identification code RIV/00216224:14310/12:00067589
Organization unit Faculty of Science
Doi http://dx.doi.org/10.5507/bp.2012.093
UT WoS 000310725900001
Keywords in English polyunsaturated fatty acids; docosahexaenoic acid; colon cancer; apoptosis; cell signalling; anticancer therapy
Tags AKR, rivok
Changed by Changed by: prof. Ing. Petr Dvořák, CSc., učo 47260. Changed: 29/4/2014 09:52.
Abstract
Background. Experimental, epidemiological and clinical data substantiate the beneficial role of n-3 polyunsaturated fatty acids (PUFAs) in preventing inflammation and cancer of the colon. This review covers the unsaturated docosahexaenoic fatty acid (DHA), describes some of its important cellular and molecular mechanisms, its interaction with another dietary lipid, butyrate and with endogenous apoptotic regulators of the tumour necrosis factor (TNF) family. We also discuss the clinical impact of this knowledge and the use of these lipids in colon cancer prevention and treatment. Results. From the literature, DHA has been shown to suppress the growth, induce apoptosis in colon cancer cells in vitro and decrease the incidence and growth of experimental tumours in vivo. Based on these data and our own experimental results, we describe and discuss the possible mechanisms of DHA anticancer effects at various levels of cell organization. We show that DHA can sensitize colon cancer cells to other chemotherapeutic/chemopreventive agents and affect the action of physiological apoptotic regulators of the TNF family. Conclusion. Use of n-3 PUFAs could be a relatively non-toxic form of supportive therapy for improving colon cancer treatment and slowing down or preventing its recurrence. However, it is necessary to use them with caution, based on solid scientific evidence of their mechanisms of action from the molecular to the cellular and organism levels.
Links
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 22/5/2024 12:53